Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bemnifosbuvir hemisulfate (AT-527) 是一种 HCV 病毒复制抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 892 | 现货 | ||
5 mg | ¥ 1,990 | 现货 | ||
10 mg | ¥ 3,230 | 现货 | ||
25 mg | ¥ 5,720 | 现货 | ||
50 mg | ¥ 8,250 | 现货 | ||
100 mg | ¥ 10,900 | 现货 |
产品描述 | Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. |
靶点活性 | SARS-CoV-2:0.47μM(EC90), HCV:5-28nM |
体外活性 | The potent in vitro activity of AT-511, the free base of bemnifosbuvir hemisulfate, against several coronaviruses, including SARS-CoV-2. In normal human airway epithelial cells, the concentration of AT-511 required to inhibit replication of SARS-CoV-2 by 90% (EC90) was 0.47?μM, very similar to its EC90 against human coronavirus (HCoV)-229E, HCoV-OC43, and SARS-CoV in Huh-7 cells[1]. |
体内活性 | When given orally to rats and monkeys, bemnifosbuvir hemisulfate preferentially delivered high levels of AT-9010 in the liver in vivo.These favorable preclinical attributes support bemnifosbuvir hemisulfate may increase SVR rates[2]. |
别名 | AT-527 |
分子量 | 1261.15 |
分子式 | C48H68F2N14O18P2S |
CAS No. | 2241337-84-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 170 mg/mL (269.60 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 0.7929 mL | 3.9646 mL | 7.9293 mL | 19.8232 mL |
5 mM | 0.1586 mL | 0.7929 mL | 1.5859 mL | 3.9646 mL | |
10 mM | 0.0793 mL | 0.3965 mL | 0.7929 mL | 1.9823 mL | |
20 mM | 0.0396 mL | 0.1982 mL | 0.3965 mL | 0.9912 mL | |
50 mM | 0.0159 mL | 0.0793 mL | 0.1586 mL | 0.3965 mL | |
100 mM | 0.0079 mL | 0.0396 mL | 0.0793 mL | 0.1982 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Bemnifosbuvir hemisulfate 2241337-84-6 Microbiology/Virology Proteases/Proteasome HCV Protease SARS-CoV Inhibitor antiviral phosphoramidate HCV AT-527 nucleotide Bemnifosbuvir pangenotypic AT 527 Bemnifosbuvir Hemisulfate guanosine SARS coronavirus AT527 Hepatitis C virus inhibit inhibitor